These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7822308)

  • 1. GH3 pituitary tumor cells contain heteromeric type I and type II receptor complexes for transforming growth factor beta and activin-A.
    Moustakas A; Takumi T; Lin HY; Lodish HF
    J Biol Chem; 1995 Jan; 270(2):765-9. PubMed ID: 7822308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of a type I serine-threonine kinase receptor for TGF-beta and activin in the rat pituitary tumor cell line GH3.
    Takumi T; Moustakas A; Lin HY; Lodish HF
    Exp Cell Res; 1995 Jan; 216(1):208-14. PubMed ID: 7813622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rat pituitary tumor cell line (GH3) expresses type I and type II receptors and other cell surface binding protein(s) for transforming growth factor-beta.
    Yamashita H; Okadome T; Franzén P; ten Dijke P; Heldin CH; Miyazono K
    J Biol Chem; 1995 Jan; 270(2):770-4. PubMed ID: 7822309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of type I receptors for transforming growth factor-beta and activin.
    ten Dijke P; Yamashita H; Ichijo H; Franzén P; Laiho M; Miyazono K; Heldin CH
    Science; 1994 Apr; 264(5155):101-4. PubMed ID: 8140412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A surface component on GH3 pituitary cells that recognizes transforming growth factor-beta, activin, and inhibin.
    Cheifetz S; Ling N; Guillemin R; Massagué J
    J Biol Chem; 1988 Nov; 263(33):17225-8. PubMed ID: 2903159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin.
    Cárcamo J; Weis FM; Ventura F; Wieser R; Wrana JL; Attisano L; Massagué J
    Mol Cell Biol; 1994 Jun; 14(6):3810-21. PubMed ID: 8196624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors.
    Attisano L; Cárcamo J; Ventura F; Weis FM; Massagué J; Wrana JL
    Cell; 1993 Nov; 75(4):671-80. PubMed ID: 8242742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-specific expression and alternate splicing of messenger ribonucleic acid encoding activin/transforming growth factor-beta receptors in human pituitary adenomas.
    Alexander JM; Bikkal HA; Zervas NT; Laws ER; Klibanski A
    J Clin Endocrinol Metab; 1996 Feb; 81(2):783-90. PubMed ID: 8636304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of type I receptor specificity by the type II receptors for TGF-beta or activin.
    Ebner R; Chen RH; Lawler S; Zioncheck T; Derynck R
    Science; 1993 Nov; 262(5135):900-2. PubMed ID: 8235612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of transforming growth factor-beta1, activin A, and their receptors in thyroid follicle cells: negative regulation of thyrocyte growth and function.
    Franzén A; Piek E; Westermark B; ten Dijke P; Heldin NE
    Endocrinology; 1999 Sep; 140(9):4300-10. PubMed ID: 10465304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and localization of inhibin/activin and activin receptors in GH3 cells, a rat pituitary adenocarcinoma cell line.
    Ying C; Zhang Z; Huang G; Li SQ; Ying SY
    J Endocrinol Invest; 1996 Jan; 19(1):6-11. PubMed ID: 8851685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The p21(RAS) farnesyltransferase alpha subunit in TGF-beta and activin signaling.
    Wang T; Danielson PD; Li BY; Shah PC; Kim SD; Donahoe PK
    Science; 1996 Feb; 271(5252):1120-2. PubMed ID: 8599089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transforming growth factor beta type II receptor can replace the activin type II receptor in inducing mesoderm.
    Bhushan A; Lin HY; Lodish HF; Kintner CR
    Mol Cell Biol; 1994 Jun; 14(6):4280-5. PubMed ID: 8196664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A chimeric serine/threonine kinase receptor system reveals the potential of multiple type II receptors to cooperate with transforming growth factor-beta type I receptor.
    Muramatsu M; Yan J; Eto K; Tomoda T; Yamada R; Arai K
    Mol Biol Cell; 1997 Mar; 8(3):469-80. PubMed ID: 9188099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional evidence for a singular repertoire of BMP receptor signal transducing proteins in the lophotrochozoan Crassostrea gigas suggests a shared ancestral BMP/activin pathway.
    Herpin A; Lelong C; Becker T; Rosa F; Favrel P; Cunningham C
    FEBS J; 2005 Jul; 272(13):3424-40. PubMed ID: 15978047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperative binding of transforming growth factor (TGF)-beta 2 to the types I and II TGF-beta receptors.
    Rodriguez C; Chen F; Weinberg RA; Lodish HF
    J Biol Chem; 1995 Jul; 270(27):15919-22. PubMed ID: 7608141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activin and inhibin binding to the soluble extracellular domain of activin receptor II.
    Donaldson CJ; Vaughan JM; Corrigan AZ; Fischer WH; Vale WW
    Endocrinology; 1999 Apr; 140(4):1760-6. PubMed ID: 10098513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects.
    Yamashita H; ten Dijke P; Huylebroeck D; Sampath TK; Andries M; Smith JC; Heldin CH; Miyazono K
    J Cell Biol; 1995 Jul; 130(1):217-26. PubMed ID: 7790373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor.
    Persson U; Souchelnytskyi S; Franzén P; Miyazono K; ten Dijke P; Heldin CH
    J Biol Chem; 1997 Aug; 272(34):21187-94. PubMed ID: 9261125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
    Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
    Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.